Skip to main content

Table 1 Demographic and clinical characteristics (combined and stratified by neurocognitive impairment)

From: Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals

Characteristics All subjects NC impaired NC unimpaired  
( n= 107) ( n= 58) ( n= 49) P value
Age, years - mean ± SD 43.7 ± 8.7 45.3 ± 9.3 41.8 ± 7.6 0.033
Gender, male - N (%) 93 (86.9%) 52 (89.7%) 42 (85.7%) 0.406
Race     
 White - N (%) 59 (55.1%) 31 (53.5%) 28 (57.1%) 0.962
 Black 34 (31.8%) 18 (31.0%) 16 (32.7%)  
 Other 14 (13.1%) 9 (15.5%) 5 (10.2%)  
AIDS - N (%) 68 (63.6%) 38 (65.5%) 30 (61.2%) 0.554
ART use - N (%) 84 (78.5%) 45 (77.6%) 39 (79.6%) 0.956
Plasma HIV VL undetectable - N (%) 53 (49.5%) 29 (50.0%) 24 (50.0%) 0.838
CSF HIV VL undetectable - N (%) 79 (73.8%) 44 (75.9%) 36 (73.5%) 0.910
Current CD4+ count (<200 cells/μL) - N (%) 22 (20.8%) 9 (15.5%) 13 (26.5%) 0.160
Current CD4+ count - median (IQR) 405 (216 to 582) 435 (260 to 589) 360 (175 to 531) 0.247
Albumin (<5 g/dL) 72 (67.9%) 37 (64.9%) 35 (71.4%) 0.474
Alcohol dependence - N (%) 25 (23.2%) 12 (20.7%) 13 (26.5%) 0.514
HGB (mean ± SD) 14.1 ± 1.5 14.1 ± 1.6 14.1 ± 1.4 0.882
AST - median (IQR) 30 (23 to 37) 31 (24 to 39) 30 (22 to 36) 0.673
ALT - median (IQR) 33 (22 to 43) 36 (23 to 43) 30 (22 to 40) 0.298
Body mass index (BMI)     0.290
BMI ≤ 25 45 (42.1%) 24 (41.4%) 21 (42.9%)  
25 < BMI < 30 45 (42.1%) 22 (37.9%) 23 (46.9%)  
BMI ≥ 30 17 (15.8%) 12 (20.7%) 5 (10.2%)